Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127) [Phase 3]
A Phase 3 study (EOS) evaluating the effect of roflumilast on lung function in COPD patients who are treated with salmeterol has completed w…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD [Phase 3]
This update notes the completion of a Phase 3 study evaluating the safety and efficacy of infliximab (Remicade) in patients with chronic obs…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. [Phase 4]
A Phase 4 randomized trial compared tiotropium 18 mcg once daily with salmeterol 50 mcg twice daily in COPD patients to assess time to first…
-
CLINICAL_TRIALS research · 2011-05-13Clinical Trial Update: A Study on Smoking-related Lung Function Abnormalities and Correlation With Serum Biomarkers in Chinese
Clinical trial update investigating smoking-related lung function abnormalities and their correlation with serum biomarkers in Chinese parti…
-
FDA approval · 2011-05-10FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for ADVAIR HFA (fluticasone propionate and salmeterol xinafoate) submitted by GlaxoSmithKline LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-05-10FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental NDA for Advair Diskus (fluticasone propionate and salmeterol) submitted by GlaxoSmithKline LLC. The approval ind…
-
FDA approval · 2011-05-10FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ipratropium bromide by Hikma Pharmaceuticals USA Inc. under ANDA 076664, updating an already…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD [Phase 2]
Phase 2 study of Trospium Inhalation Powder (TrIP) in subjects with chronic obstructive pulmonary disease has completed. Results were posted…
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
A Phase 2 study evaluating inhaled bimosiamose for safety and efficacy in patients with moderate to severe COPD has completed. The trial was…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 clinical trial update evaluating the bronchodilatory effect of NVA237 in chronic obstructive pulmonary disease, with results posted …
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD [Phase 4]
Phase 4 clinical trial ANTEAB studying early antibiotic therapy in ICU management of acute exacerbations of COPD has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacodynamics of the experimental drug QAX028 compared with open-label tiotropium brom…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 4]
Phase 4 clinical trial update evaluating how bronchodilators affect oxygen kinetics during exercise in patients with chronic obstructive pul…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial at Queen's University assessing the effects of bronchodilators in mild chronic obstructive pulmonary disease has co…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients [Phase 4]
A Phase 4 clinical trial comparing different exercise training programs in patients with chronic obstructive pulmonary disease (COPD), inclu…
-
FDA approval · 2011-04-13FDA Approved: THEOPHYLLINE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's original application for Theophylline as a generic drug. The approval indicates authorization for a generic…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1) [Phase 3]
Phase 3 patient-handling study of a mometasone furoate/formoterol fumarate MDI with an integrated dose counter in adolescents and adults wit…
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies
A clinical trial update comparing COPD patients treated with fluticasone propionate/salmeterol versus other maintenance therapies, focusing …
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) Sputum
This completed study assessed the in vitro effects of Cationic Airway Lining Modulators (CALM) on sputum from patients with chronic obstruct…
-
FDA approval · 2011-04-08FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Terbutaline Sulfate from Amneal Pharmaceuticals of New York LLC, authorizing a modification to a…
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
The study compared initiating maintenance therapy with Fluticasone Propionate/Salmeterol (FSC) versus anticholinergic therapy including Tiot…
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients. [Phase 4]
A Phase 4 clinical trial assessed how Symbicort Forte Turbohaler particles deposit in the lungs and the acute effects in COPD patients.
-
CLINICAL_TRIALS research · 2011-04-05Clinical Trial Update: The Effect on Small Airways of Addition of Theophylline as Inducer of Histone Deacilase Activity for Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Treated With Inhaled Steroids and Long Acting Beta Agonists [NA]
A clinical trial evaluating whether adding theophylline to inhaled steroids and long-acting beta agonists affects small airway function in p…
-
CLINICAL_TRIALS research · 2011-04-05Clinical Trial Update: Spirometry in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) Patients
A clinical trial update focusing on spirometry assessments in mechanically ventilated patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: The Effects of a Self-management Intervention on Low Literacy Patients With Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial evaluating the effects of a self-management intervention among low-literacy patients with chronic obstructive pul…